Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00139841
Status:
COMPLETED
Last Update Posted:
2014-05-09
First Post:
2005-08-18
Brief Title:
Safety and Efficacy of Treanda Bendamustine HCl in Patients With Indolent Non-Hodgkins Lymphoma NHL Who Are Refractory to Rituximab
Sponsor:
Cephalon
Organization:
Teva Branded Pharmaceutical Products RD Inc